If you have already “checked your cholesterol,” you may still be missing one of the most important cardiovascular risk markers we use in modern preventive cardiology: lipoprotein(a), usually written Lp(a) and pronounced “L-P-little-a.”
At Los Angeles Heart Specialists in Tarzana, patients often arrive with years of “normal” cholesterol reports—yet a strong family history of early heart attack, stroke, or aortic valve disease. In many of those cases, the missing piece is Lp(a).
This article explains what Lp(a) is, who should consider testing, what a result can (and cannot) tell us, and how we use it in a careful prevention plan. It is educational, not a personal diagnosis. Decisions about testing and treatment belong in a clinician–patient relationship.
Cholesterol travels in the blood inside lipoprotein particles. LDL (“bad cholesterol”) is the particle most people know. Lp(a) is a distinct particle: it resembles LDL but has an extra protein, apolipoprotein(a), attached.
That structural difference matters. Elevated Lp(a) is associated with a higher lifetime risk of atherosclerotic cardiovascular disease—coronary artery disease, heart attack, stroke—and with calcific aortic valve disease in some people. The association is supported by large epidemiologic and genetic studies; it is not a social-media fad.
Two practical points patients find surprising:
Guidelines and expert consensus increasingly support measuring Lp(a) at least once in adulthood, because a single result often characterizes lifelong exposure. Testing is especially worth discussing if you have:
If you live in the San Fernando Valley or greater Los Angeles and are building a serious prevention plan, Lp(a) belongs in the same conversation as blood pressure, ApoB/LDL, diabetes risk, smoking, sleep apnea, and family history—not as an afterthought.
An elevated Lp(a) is a risk factor, not a destiny. Many people with high Lp(a) never have an event, especially when other risks are controlled. Likewise, a normal Lp(a) does not grant immunity from heart disease.
Interpretation depends on the laboratory method and units (mg/dL vs nmol/L). Comparing results across different assays can be misleading. Your cardiologist should interpret your number in clinical context—not in isolation.
Also important: an Lp(a) result does not replace imaging, stress testing, or symptom evaluation when those are indicated. It refines risk; it does not image your arteries.
There is not yet a widely available medication approved solely to lower Lp(a) for outcome prevention in everyday practice in the way statins transformed LDL care—though research is active, and that landscape may change. Until then, a responsible approach usually includes:
We do not tell patients that “fixing Lp(a)” by itself guarantees fewer heart attacks. We tell them the truth: knowing Lp(a) helps us stop guessing about inherited risk and build a more honest prevention plan.
Because Lp(a) is strongly genetic, an elevated value is also a family signal. Adult first-degree relatives may wish to discuss once-in-a-lifetime testing with their clinicians. This is information-sharing—not a command to panic or start prescription therapy without medical advice.
For parents of young adults in Los Angeles, the most useful gift is often a clear family cardiac history plus a short list of completed tests (lipid panel, Lp(a), blood pressure trends), not a stack of unverified internet protocols.
Lp(a) is one piece of a broader cardiovascular assessment. Depending on your history, your cardiology visit may also address ApoB or non-HDL cholesterol, blood pressure, glucose, kidney function, sleep, exercise, family history, and—when appropriate—coronary artery calcium imaging.
The goal is not to order every test. It is to choose the information that can change a decision. For some people, Lp(a) provides the missing explanation for premature events in the family; for others, it simply reinforces the importance of getting the basics right for decades.
If you live in Tarzana, Encino, Sherman Oaks, Woodland Hills, or nearby Los Angeles communities and have a strong family history of early heart disease, ask whether an Lp(a) test belongs in your prevention plan. A standard lipid panel may look reassuring while leaving an inherited risk factor unmeasured.
At Los Angeles Heart Specialists, we use Lp(a) results in context—alongside your family history, exam, blood pressure, cholesterol pattern, and overall goals. The result is not a prediction carved in stone. It is a piece of information that can help you and your clinician make earlier, clearer decisions.
This article is for education and does not replace individualized medical advice. Testing and treatment decisions should be made with a qualified clinician.
